Potential Genetic Target Identified as Postsurgical Pain Marker
the Clinical Pain Advisor take:
Being able to predict which patients are prone to developing chronic pain after surgery can enable clinicians to better prepare for postoperative pain management.
Published in Anesthesiology, findings from a study by Liu et al revealed that polymorphisms in the spinal cathepsin G (CTSG) gene may be a marker of pain hypersensitivity and a potential target for pain management. They found that CTSG was the most up-regulated gene.
The researchers then evaluated the association between CTSG gene polymorphisms and the risk of chronic postsurgical pain in 1152 surgical patients. Overall, 246 patients in the gene-association study reported chronic postsurgical pain at 12-month follow-up (21.4%).
“Inhibition of CTSG attenuated chronic inflammation-associated hyperalgesia, and this was accompanied with a decrease in neutrophilic infiltration and a lower level of IL-1β in the spinal dorsal horn,” the researchers noted.
Those with homozygous A alleles at polymorphism rs2070697 and rs2236742 had a lower risk for chronic postsurgical pain than those with wild-type alleles (adjusted odds ratios: 0.67 [95% CI 0.26-0.99] and 0.34 [95% CI: 0.21-0.98], respectively).
“Taken together, our data suggest that CTSG modulates pain hypersensitivity and is a potential target for pain management,” the researchers wrote.
In the future clinicians may be able to use the presence or absence of CTSG polymorphisms prior to surgery to facilitate more appropriate chronic postsurgical pain prevention plans, they suggested.
Data suggest that the CTSG gene modulates pain hypersensitivity.
Clinical Pain Advisor Articles
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Emergency Physicians Offer Recommendations for Identifying and Managing Opioid Use Disorder
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Men With Migraines May Have Increased Serum Estradiol, Androgen Deficiency
- Fremanezumab Effective in Reversion of Chronic Migraine to Episodic Migraine
- Endocannabinoids May Be Elevated in Women With Fibromyalgia
- Putting Patients in the Physician's Seat: Smartphone Technology Is Changing the Healthcare Landscape
- Cardiovascular, Psychiatric Comorbidity Patterns Evident in Migraine